Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0473 per EA under NDC 00904702761. Its NADAC has been published 192 times since Oct 26, 2022.
Strength
5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904702761
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209823On Market Since
11/15/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 192 times since Oct 26, 2022, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0765 (Nov 16, 2022) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0508 |
| Average price | $0.0551 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 192 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0473 per EA (NDC 00904702761), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 38.2%. It has been tracked across 192 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Oct 26, 2022, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.0765 (Nov 16, 2022), with a median of $0.0508 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 00904702761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification